Clinical Trial Update: Pediatric Study to Evaluate Treatment of Persistent Moderate or Severe Asthma With the Association Fluticasone 250 mcg/Dose and Salmeterol 50 mcg/Dose - ADERE PROJECT [Phase 4]

View source ↗

Summary

A Phase 4 pediatric trial evaluated the combination inhaled therapy of fluticasone 250 mcg/dose with salmeterol 50 mcg/dose for persistent moderate-to-severe as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone propionate/salmeterol (fluticasone propionate/salmeterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED